share_log

Mangoceuticals | EFFECT: Others

Mangoceuticals | EFFECT: Others

Mangoceuticals | EFFECT:其他
美股SEC公告 ·  09/06 06:06

Moomoo AI 已提取核心訊息

Mangoceuticals, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC). The SEC has declared the company's Form S-1 effective as of September 5, 2024, at 4:30 P.M. This form is typically used by companies to register new securities for sale to the public, indicating that Mangoceuticals may be preparing to offer new shares. The effectiveness of the form marks a crucial step in the process, allowing the company to proceed with its offering.
Mangoceuticals, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC). The SEC has declared the company's Form S-1 effective as of September 5, 2024, at 4:30 P.M. This form is typically used by companies to register new securities for sale to the public, indicating that Mangoceuticals may be preparing to offer new shares. The effectiveness of the form marks a crucial step in the process, allowing the company to proceed with its offering.
作爲一家在美國上市的公司,Mangoceuticals公司在美國證券交易委員會(SEC)取得了重要的里程碑。SEC已經宣佈該公司的S-1表格自2024年9月5日下午4:30生效。該表格通常被公司用於註冊新的證券以供公開出售,這表明Mangoceuticals可能正在準備提供新股份。該表格的生效標誌着整個過程中的重要一步,使得公司能夠繼續進行其股票發行。
作爲一家在美國上市的公司,Mangoceuticals公司在美國證券交易委員會(SEC)取得了重要的里程碑。SEC已經宣佈該公司的S-1表格自2024年9月5日下午4:30生效。該表格通常被公司用於註冊新的證券以供公開出售,這表明Mangoceuticals可能正在準備提供新股份。該表格的生效標誌着整個過程中的重要一步,使得公司能夠繼續進行其股票發行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息